Moving Beyond the Post-COVID Era: What 2024 Looks Like for Pharmaceutical Manufacturing
by Kieth Koehler It’s no secret that the pharmaceutical manufacturing industry faced multifaceted challenges both during and after the COVID-19 pandemic. These entrenched problems ranged from disruptions in the supply chain to regulatory hurdles and workforce issues, among others. However, in the category of lessons learned, it’s vital to note that these unforeseen setbacks impacted more […]